8158.HK - China Regenerative Medicine International Limited

HKSE - HKSE Delayed Price. Currency in HKD
Currency in HKD

Valuation Measures

Market Cap (intraday) 53.59B
Enterprise Value 33.53B
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.43
Price/Book (mrq)1.91
Enterprise Value/Revenue 38.31
Enterprise Value/EBITDA 6-19.58

Financial Highlights

Fiscal Year
Fiscal Year Ends Apr 30, 2017
Most Recent Quarter (mrq)Jul 30, 2017
Profitability
Profit Margin -39.83%
Operating Margin (ttm)-54.58%
Management Effectiveness
Return on Assets (ttm)N/A
Return on Equity (ttm)-9.27%
Income Statement
Revenue (ttm)425.33M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)2,512.70%
Gross Profit (ttm)138M
EBITDA -180.44M
Net Income Avi to Common (ttm)-169.4M
Diluted EPS (ttm)-0.010
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)598.28M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)754.41M
Total Debt/Equity (mrq)39.54
Current Ratio (mrq)N/A
Book Value Per Share (mrq)0.11
Cash Flow Statement
Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History
Beta N/A
52-Week Change 3-30.18%
S&P500 52-Week Change 317.63%
52 Week High 30.310
52 Week Low 30.181
50-Day Moving Average 30.213
200-Day Moving Average 30.227
Share Statistics
Avg Vol (3 month) 329.4M
Avg Vol (10 day) 329.12M
Shares Outstanding 517.59B
Float 14.13B
% Held by Insiders 141.80%
% Held by Institutions 14.59%
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 46.22%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.00
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 24, 2002
Last Split Factor (new per old) 24/1
Last Split Date 3Aug 29, 2007